RIF1 and cancer: Our finding that LumA, LumB, and HER2E cancers shift towards expressing a higher proportion of RIF1-S (Figure 2B) is therefore consistent with the general bias for Short exons to be skipped in LumA, LumB, and HER2E tumours.